The effect of selective modification of tryptophan, lysine and arginine residues of basic brain protein on encephalitogenic activity.
D000812:Anhydrides / Q000494:pharmacology; D000818:Animals; D000941:Antigens / Q000032:analysis; D001120:Arginine / Q000032:analysis; D001921:Brain / Q000276:immunology; D001923:Brain Chemistry; D002074:Butanones / Q000494:pharmacology; D002417:Cattle; D002482:Cellulose; D004586:Electrophoresis; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology*; D000939:Epitopes / Q000032:analysis; D006018:Glycols / Q000494:pharmacology; D008239:Lysine / Q000032:analysis; D009419:Nerve Tissue Proteins / Q000032:analysis*; D009578:Nitrobenzenes / Q000494:pharmacology; D009596:Nitrophenols / Q000494:pharmacology; D013053:Spectrophotometry; D014364:Tryptophan / Q000032:analysis
D000812:Anhydrides; D000941:Antigens; D002074:Butanones; D000939:Epitopes; D006018:Glycols; D009419:Nerve Tissue Proteins; D009578:Nitrobenzenes; D009596:Nitrophenols; D014364:Tryptophan; D002482:Cellulose; D001120:Arginine; D008239:Lysine